comparemela.com

Objective To examine the association between prescriber workforce exit, long term opioid treatment discontinuation, and clinical outcomes.

Design Quasi-experimental difference-in-differences study

Setting 20% sample of US Medicare beneficiaries, 2011-18.

Participants People receiving long term opioid treatment whose prescriber stopped providing office based patient care or exited the workforce, as in the case of retirement or death (n=48 079), and people whose prescriber did not exit the workforce (n=48 079).

Main outcomes Discontinuation from long term opioid treatment, drug overdose, mental health crises, admissions to hospital or emergency department visits, and death. Long term opioid treatment was defined as at least 60 days of opioids per quarter for four consecutive quarters, attributed to the plurality opioid prescriber. A difference-in-differences analysis was used to compare individuals who received long term opioid treatment and who had a prescriber leave the workforce to propensity-matched patients on long term opioid treatment who did not lose a prescriber, before and after prescriber exit.

Results Discontinuation of long term opioid treatment increased from 132 to 229 per 10 000 patients who had prescriber exit from the quarter before to the quarter after exit, compared with 97 to 100 for patients who had a continuation of prescriber (adjusted difference 1.22 percentage points, 95% confidence interval 1.02 to 1.42). In the first quarter after provider exit, when discontinuation rates were highest, a transient but significant elevation was noted between the two groups of patients in suicide attempts (adjusted difference 0.05 percentage points (95% confidence interval 0.01 to 0.09)), opioid or alcohol withdrawal (0.14 (0.01 to 0.27)), and admissions to hospital or emergency department visits (0.04 visits (0.01 to 0.06)). These differences receded after one to two quarters. No significant change in rates of overdose was noted. Across all four quarters after prescriber exit, an increase was reported in the rate of mental health crises (0.39 percentage points (95% confidence interval 0.08 to 0.69)) and opioid or alcohol withdrawal (0.31 (0.014 to 0.58)), but no change was seen for drug overdose (−0.12 (−0.41 to 0.18)).

Conclusions The loss of a prescriber was associated with increased occurrences of discontinuation of long term opioid treatment and transient increases in adverse outcomes, such as suicide attempts, but not other outcomes, such as overdoses. Long term opioid treatment discontinuation may be associated with a temporary period of adverse health impacts after accounting for unobserved confounding.

No additional data available.

Related Keywords

United States ,Stanford University ,California ,New York ,San Francisco ,Americans ,American ,Adrienneh Sabety ,Michaell Barnett ,Marema Gaye ,Hannaht Neprash ,Linkedin ,Medicaid Services ,Harvard University ,Instagram ,University Of Minnesota ,Twitter ,Retirement Research Foundation For ,Centers For Medicare ,Cnn ,Bloomberg ,Harvard Th Chan School Of Public Heath ,National Institute On Aging ,Harvard Th Chan School Of Public Health ,National Institute On ,Facebook ,New York Times ,Medicare Advantage ,Public Health ,Retirement Research Foundation ,National Institute ,San Francisco Chronicle ,Hospital Review ,Open Access ,Creative Commons Attribution Non Commercial ,

© 2024 Vimarsana

comparemela.com © 2020. All Rights Reserved.